GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Telo Genomics Corp (OTCPK:TDSGF) » Definitions » Price-to-Free-Cash-Flow
中文

Telo Genomics (Telo Genomics) Price-to-Free-Cash-Flow : N/A (As of Apr. 25, 2024)


View and export this data going back to 2016. Start your Free Trial

What is Telo Genomics Price-to-Free-Cash-Flow?

As of today (2024-04-25), Telo Genomics's share price is $0.1233. Telo Genomics's Free Cash Flow per Share for the trailing twelve months (TTM) ended in Dec. 2023 was $-0.03. Hence, Telo Genomics's Price-to-Free-Cash-Flow Ratio for today is N/A.

The historical rank and industry rank for Telo Genomics's Price-to-Free-Cash-Flow or its related term are showing as below:

TDSGF's Price-to-Free-Cash-Flow is not ranked *
in the Medical Diagnostics & Research industry.
Industry Median: 27.41
* Ranked among companies with meaningful Price-to-Free-Cash-Flow only.

Telo Genomics's Free Cash Flow per Share for the three months ended in Dec. 2023 was $-0.01. Its Free Cash Flow per Share for the trailing twelve months (TTM) ended in was $-0.03.

During the past 3 years, the average Free Cash Flow per Share Growth Rate was -5.80% per year. During the past 5 years, the average Free Cash Flow per Share Growth Rate was 22.20% per year. During the past 10 years, the average Free Cash Flow per Share Growth Rate was 12.40% per year.

During the past 12 years, Telo Genomics's highest 3-Year average Free Cash Flow per Share Growth Rate was 64.90% per year. The lowest was -177.70% per year. And the median was -3.85% per year.


Telo Genomics Price-to-Free-Cash-Flow Historical Data

The historical data trend for Telo Genomics's Price-to-Free-Cash-Flow can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Telo Genomics Price-to-Free-Cash-Flow Chart

Telo Genomics Annual Data
Trend Dec13 Dec14 Dec15 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23
Price-to-Free-Cash-Flow
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Telo Genomics Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Price-to-Free-Cash-Flow Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Telo Genomics's Price-to-Free-Cash-Flow

For the Diagnostics & Research subindustry, Telo Genomics's Price-to-Free-Cash-Flow, along with its competitors' market caps and Price-to-Free-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Telo Genomics's Price-to-Free-Cash-Flow Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Telo Genomics's Price-to-Free-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Telo Genomics's Price-to-Free-Cash-Flow falls into.



Telo Genomics Price-to-Free-Cash-Flow Calculation

Telo Genomics's Price-to-Free-Cash-Flow ratio for today is calculated as

Price-to-Free-Cash-Flow Ratio=Share Price/ Free Cash Flow per Share (TTM)
=0.1233/-0.03
=N/A

Telo Genomics's Share Price of today is $0.1233.
Telo Genomics's Free Cash Flow per Share for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.03.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

Price-to-Free-Cash-Flow Ratio=Market Cap/Free Cash Flow

Telo Genomics  (OTCPK:TDSGF) Price-to-Free-Cash-Flow Explanation

Free Cash Flow is considered more important than earnings by value investors. The reason is because, in principle, only the net cash that can be taken from the business belongs to shareholders. This Free Cash Flow can be used to grow the business, reduce debt or return to shareholders in dividends or share buybacks.

In a DCF Calculation Free Cash Flow is used to determine the intrinsic value of companies.


Be Aware

In real business, Free Cash Flow can be affected by the change in accounts receivable, accounts payable, management's decision on expansion, etc. Therefore, investors should look at the Free Cash Flow over the longer term. Long-term average of Free Cash Flow is a more reliable indicator for real free cash flow.


Telo Genomics Price-to-Free-Cash-Flow Related Terms

Thank you for viewing the detailed overview of Telo Genomics's Price-to-Free-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.


Telo Genomics (Telo Genomics) Business Description

Traded in Other Exchanges
Address
101 College Street, Suite 200, MaRS Centre, South Tower, Toronto, ON, CAN, M5G 1L7
Telo Genomics Corp is a personalized medicine company. The company through its wholly-owned subsidiary is engaged in the development and commercialization of diagnostic and prognostic products. The company is developing diagnostic and prognostic products for cancer and neurological disorders.